Showing results (81-90 of 317) with videos related to
Sort By:
Pageof 32
Ciba Foundation Symposium|January 1, 1991
Simulation analysis of the stability mutants R96H of bacteriophage T4 lysozyme and I96A of barnaseM Karplus, M Prévost, B Tidor, et al.Journal of Hepatology|September 1, 1990
Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administrationJ Fevery, E Van Cutsem, F Nevens, et al.European Journal of Gastroenterology & Hepatology|December 17, 1998
Intestinal metaplasia in gastric malignancy: a comparison between carcinoma and lymphomaA Driessen, N Ectors, J Creemers, et al.European Journal of Biochemistry|September 2, 1985
Scatter analysis of discrete-sized chromatin fragments favours a cylindrical organizationI Lasters, L Wyns, S Muyldermans, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2012
HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?D Hompes, J Tiek, A Wolthuis, et al.International Journal of Colorectal Disease|January 1, 1989
Risk factors which determine the long term outcome of Neodymium-YAG laser palliation of colorectal carcinomaE Van Cutsem, A Boonen, K Geboes, et al.Acta Gastro-Enterologica Belgica|May 10, 2012
Analysis of HER2 expression and gene amplification in adenocarcinoma of the stomach and the gastro-oesophageal junction: rationale for the Belgian way of workingA Jouret-Mourin, A Hoorens, G De Hertogh, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1990
Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquidsJ L Urbain, G Vantrappen, J Janssens, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)H Piessevaux, M Buyse, W De Roock, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 31, 2016
FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL studyC-H Köhne, G Poston, G Folprecht, et al.Pageof 32